FSGEX | SSGVX | FSGEX / SSGVX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 15 years | 10 years | - |
Gain YTD | 7.193 | 6.422 | 112% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 52.1B | N/A | - |
Annual Yield % from dividends | 2.77 | 2.84 | 98% |
Returns for 1 year | 10.84 | 10.17 | 107% |
Returns for 3 years | 14.74 | 13.37 | 110% |
Returns for 5 years | 33.35 | 32.35 | 103% |
Returns for 10 years | 53.74 | 62.06 | 87% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SHPCX | 13.13 | -0.03 | -0.23% |
Saratoga Health & Biotechnology C | |||
SBIYX | 10.99 | -0.10 | -0.90% |
ClearBridge International Value I | |||
GSCLX | 29.16 | -0.69 | -2.31% |
Goldman Sachs Large Cap Gr Insghts Svc | |||
SAGAX | 53.06 | -1.61 | -2.94% |
Virtus Zevenbergen Innovative Gr Stk A | |||
OEGIX | 33.41 | -1.26 | -3.63% |
Invesco Discovery Mid Cap Growth R6 |